1. Home
  2. IVVD vs GROV Comparison

IVVD vs GROV Comparison

Compare IVVD & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • GROV
  • Stock Information
  • Founded
  • IVVD 2020
  • GROV 2016
  • Country
  • IVVD United States
  • GROV United States
  • Employees
  • IVVD N/A
  • GROV N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • IVVD Health Care
  • GROV Consumer Discretionary
  • Exchange
  • IVVD Nasdaq
  • GROV Nasdaq
  • Market Cap
  • IVVD 63.4M
  • GROV 53.5M
  • IPO Year
  • IVVD 2021
  • GROV N/A
  • Fundamental
  • Price
  • IVVD $0.52
  • GROV $1.47
  • Analyst Decision
  • IVVD Strong Buy
  • GROV Buy
  • Analyst Count
  • IVVD 3
  • GROV 2
  • Target Price
  • IVVD $3.85
  • GROV $1.35
  • AVG Volume (30 Days)
  • IVVD 1.2M
  • GROV 101.6K
  • Earning Date
  • IVVD 08-14-2025
  • GROV 08-07-2025
  • Dividend Yield
  • IVVD N/A
  • GROV N/A
  • EPS Growth
  • IVVD N/A
  • GROV N/A
  • EPS
  • IVVD N/A
  • GROV N/A
  • Revenue
  • IVVD $46,210,000.00
  • GROV $185,354,000.00
  • Revenue This Year
  • IVVD $345.16
  • GROV N/A
  • Revenue Next Year
  • IVVD $161.08
  • GROV $11.10
  • P/E Ratio
  • IVVD N/A
  • GROV N/A
  • Revenue Growth
  • IVVD 1941.08
  • GROV N/A
  • 52 Week Low
  • IVVD $0.35
  • GROV $1.02
  • 52 Week High
  • IVVD $2.74
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 32.49
  • GROV 54.99
  • Support Level
  • IVVD $0.48
  • GROV $1.41
  • Resistance Level
  • IVVD $0.65
  • GROV $1.60
  • Average True Range (ATR)
  • IVVD 0.06
  • GROV 0.10
  • MACD
  • IVVD -0.03
  • GROV 0.00
  • Stochastic Oscillator
  • IVVD 11.35
  • GROV 60.23

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: